Administration of Nanocurcumin in Mice Models of Endometriosis as an Effort to Improve Folliculogenesis
article
OA: diamond
CC0
⤵ 1 in-corpus citation
Abstract
The purpose of this study is to ascertain how nanocurcumin 0-50 nm affects malondialdehyde (MDA) levels, folliculogenesis, and the quantity of corpus luteum (CL) in a mice model of endometriosis. 24 mice were used in this scientific experiment, and they were split up into 4 treatment groups; positive control (C+) as mice model of endometriosis, Treatment 1 (T1) as mice model of endometriosis given nanocurcumin 0-50 nm (2.5 mg/KgBW) PO, Treatment 2 (T2) mice given nanocurcumin (5 mg/KgBW) and Treatment 3 (T3) as mice model of endometriosis treated with nanocurcumin (10 mg/KgBW). The nanocurcumin was administered for 14 days. The findings demonstrated that, out of all treatment groups, T3 had the lowest MDA level (20.78±4.58 ng/ml) and statistically significant (p<0.05) compared to C+, T1 and T2. Significant differences (p<0.05) were observed in the number of primary, secondary, and tertiary follicles at T3, from C+, T1, and T2, according to the folliculogenesis profile. Although the number of Graafian follicles tended to grow, there was no discernible difference between the number of Graafian follicles and the CL. It can be concluded that the administration of nanocurcumin for 14 days decreased MDA levels and increased the folliculogenesis profile. Administration of nanocurcumin at a dose of 10 mg/KgBW caused a decrease in MDA levels and an improvement in the folliculogenesis profile. Thus, administering nanocurcumin could improve the quality of folliculogenesis in endometriosis sufferers and improve reproductive health.
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (38)
- Antral follicle count is reduced in the presence of endometriosis: a systematic review and meta-analysis via openalex
- Curcumin improves growth factors expression of bovine cumulus-oocyte complexes cultured in peritoneal fluid of women with endometriosis via openalex
- Diagnosis and management of endometriosis via openalex
- Diminished Ovarian Reserve in Endometriosis: Insights from In Vitro, In Vivo, and Human Studies—A Systematic Review via openalex
- Endometriosis via openalex
- Endometriosis and Infertility via openalex
- Endometriosis and infertility: a committee opinion via openalex
- Endometriosis: Pathogenesis, diagnosis, therapy and association with cancer (Review) via openalex
- Evaluating the risk of endometriosis based on patients’ self-assessment questionnaires via openalex
- Evolution of medical treatment for endometriosis: back to the roots? via openalex
- Iron availability is increased in individual human ovarian follicles in close proximity to an endometrioma compared with distal ones via openalex
- Oxidative stress in the pelvic cavity and its role in the pathogenesis of endometriosis via openalex
- Pathogenesis and pathophysiology of endometriosis via openalex
- W2888676896 via openalex
- W2913270404 via openalex
- W2944310141 via openalex
- W2998937258 via openalex
- W3118705072 via openalex
- W3119570341 via openalex
- W3183278418 via openalex
- W4294084369 via openalex
- W4385899353 via openalex
- W4386859832 via openalex
- W4390730641 via openalex
- W4391246526 via openalex
- W4391818371 via openalex
- W1982266454 via openalex
- W1991178530 via openalex
- W2014690573 via openalex
- W2024177211 via openalex
- W2033431239 via openalex
- W2123205017 via openalex
- W2140906896 via openalex
- W2142120438 via openalex
- W2142212303 via openalex
- W2187230559 via openalex
- W2727005504 via openalex
- W2797118610 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK